Primary liver transplantation for autoimmune hepatitis: A comparative analysis of the European Liver Transplant Registry

The principal aim of this study was to compare the probability of and potential risk factors for death and graft loss after primary adult and pediatric liver transplantation in patients undergoing transplantation for autoimmune hepatitis (AIH) to those in patients undergoing transplantation for primary biliary cirrhosis (PBC; used as the reference group) or alcoholic cirrhosis (used as an example of a nonautoimmune liver disease). The 5‐year survival of patients undergoing transplantation for AIH (n = 827) was 0.73 [95% confidence interval (CI) = 0.67‐0.77]. This was similar to that of patients undergoing transplantation for alcoholic cirrhosis (0.74, 95% CI = 0.72‐0.76, n = 6424) but significantly worse than that of patients undergoing transplantation for PBC (0.83, 95% CI = 0.80‐0.85, n = 1588). Fatal infectious complications occurred at an increased rate in patients with AIH (hazard ratio = 1.8, P = 0.002 with PBC as the reference). The outcome of pediatric AIH patients was similar to that of adult patients undergoing transplantation up to the age of 50 years. However, the survival of AIH patients undergoing transplantation beyond the age of 50 years (0.61 at 5 years, 95% CI = 0.51‐0.70) was significantly reduced in comparison with the survival of young adult AIH patients (0.78 at 18‐34 years, 95% CI = 0.70‐0.86) and in comparison with the survival of patients of the same age group with PBC or alcoholic cirrhosis. In conclusion, age significantly affects patient survival after liver transplantation for AIH. The increased risk of dying of infectious complications in the early postoperative period, especially above the age of 50 years, should be acknowledged in the management of AIH patients with advanced‐stage liver disease who are listed for liver transplantation. It should be noted that not all risk factors relevant to patient and graft survival could be analyzed with the European Liver Transplant Registry database. Liver Transpl , 2010. © 2010 AASLD.

[1]  J. Trotter,et al.  Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  K. Boberg,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Simplified Criteria for the Diagnosis of Autoimmune Hepatitis , 2008 .

[3]  D. Vergani,et al.  Autoimmune paediatric liver disease. , 2008, World journal of gastroenterology.

[4]  J. Neuberger,et al.  The impact of disease recurrence on graft survival following liver transplantation: a single centre experience , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[5]  P. Tandon,et al.  Bacterial infections, sepsis, and multiorgan failure in cirrhosis. , 2008, Seminars in liver disease.

[6]  M. Manns,et al.  Treatment challenges and investigational opportunities in autoimmune hepatitis , 2005, Hepatology.

[7]  A. Czaja,et al.  Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis , 2004, Hepatology.

[8]  M. Manns,et al.  Long‐term outcome of liver transplantation for autoimmune hepatitis , 2004, Clinical transplantation.

[9]  D. Jaeck,et al.  Evolution of liver transplantation in Europe: Report of the European Liver Transplant Registry , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[11]  L. Grande,et al.  Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centers , 2003, Transplantation.

[12]  T. Heffron,et al.  Adult and pediatric liver transplantation for autoimmune hepatitis. , 2003, Transplantation proceedings.

[13]  J. Neuberger.  Transplantation for Autoimmune Hepatitis , 2002, Seminars in liver disease.

[14]  G. Gerken,et al.  Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. , 2001, Zeitschrift fur Gastroenterologie.

[15]  R. Wiesner,et al.  Recurrent autoimmune hepatitis after orthotopic liver transplantation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[16]  M. Schwartz,et al.  Liver transplantation for autoimmune hepatitis , 2000, Hepatology.

[17]  J. Roberts,et al.  Liver transplantation for autoimmune hepatitis: rejection and recurrence. , 1999, Transplantation proceedings.

[18]  E. Elias,et al.  Recurrence of autoimmune hepatitis after liver transplantation. , 1999, Transplantation.

[19]  E. Elias,et al.  Factors associated with progression of the disease before transplantation in patients with autoimmune hepatitis. , 1999, Liver.

[20]  M. L. de la Mata,et al.  Outcome of autoimmune hepatitis after liver transplantation. , 1998, Transplantation.

[21]  D. R. Parker,et al.  Autoimmune hepatitis in the elderly , 1998, Gut.

[22]  M. Omata,et al.  Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. , 1997, Journal of hepatology.

[23]  D. R. Parker,et al.  Type I autoimmune hepatitis is primarily a disease of later life. , 1997, QJM : monthly journal of the Association of Physicians.

[24]  P. Mcmaster,et al.  Liver transplantation for autoimmune hepatitis: a 12-year experience. , 1997, Transplantation proceedings.

[25]  T. Therneau,et al.  Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. , 1996, Gastroenterology.

[26]  A. Lohse,et al.  Evidence for spontaneous immunosuppression in autoimmune hepatitis , 1995, Hepatology.

[27]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[28]  B. Portmann,et al.  Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. , 2008, Journal of hepatology.

[29]  O. Farges,et al.  Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. , 1999, Journal of hepatology.

[30]  K. Detre,et al.  Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS Liver Transplant Registry. , 1998, Clinical transplants.